A recent study showed that GSK-3β activity is upregulated in cognitively impaired T2DM patients, in comparison with DM patients with no cognitive impairment, thus confirming the association between GSK-3β peripheral activity and cognitive impairment in T2DM [96]. Here, GSK3B is linked to Cognitive impairment.